Sanara MedTech (SMTI) Cash from Investing Activities (2010 - 2026)

Sanara MedTech has reported Cash from Investing Activities for 15 years, with the latest figure at -$43772.0 in Q1 2026.

• For the quarter ending Q1 2026, Cash from Investing Activities rose 99.15% year-over-year to -$43772.0; the trailing twelve-month figure through Mar 2026 stood at -$9.8 million (up 16.1% YoY), and the FY2025 full-year result was -$15.0 million, down 126.48% from the prior year.
• Cash from Investing Activities for Q1 2026 stood at -$43772.0, up from -$2.4 million in the prior quarter.
• The five-year high for Cash from Investing Activities was -$12945.0 in Q2 2023, with the low at -$10.1 million in Q3 2023.
• Historically, Cash from Investing Activities has averaged -$2.1 million across 5 years, with a median of -$376954.0 in 2022.
• Annual changes were most pronounced in 2023 — Cash from Investing Activities soared 99.38% — and 2025, when it sank 7769.97%.
• Sanara MedTech's Cash from Investing Activities stood at -$376954.0 in 2022, then jumped by 85.6% to -$54276.0 in 2023, then plunged by 139.51% to -$129994.0 in 2024, then slumped by 1781.07% to -$2.4 million in 2025, then surged by 98.21% to -$43772.0 in 2026.
• The last three Cash from Investing Activities figures came in at -$43772.0 (Q1 2026), -$2.4 million (Q4 2025), and -$3.4 million (Q3 2025), per Business Quant data.